From bench to bedside: the history and progress of CAR T cell therapy is a research paper published in Frontiers in Immunology (2023). On theSindex it has a DataRank of 0. It has been cited 442 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01CA211861, R61AI133697
NIAID NIH HHS
Grant: R33 AI133697
NCI NIH HHS
Grant: R01 CA211861
NIAID NIH HHS
Grant: R61 AI133697
National Institutes of Health
Grant: 5R33AI133697-05
Silencing of HIV-1 proviruses by epigenetically targeting transcriptional elongation
National Institutes of Health
Grant: 7R61AI133697-02
Silencing of HIV-1 proviruses by epigenetically targeting transcriptional elongation
National Institutes of Health
Grant: 1R01CA211861-01A1
The Germ Cell Gene TDRD1 As A Novel Prostate Cancer Biomarker
FWCI
51.71
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals